Analyst CornerAnalyst Corner: The US Drugstore Sector Needs a New Playbook To Build a Stronger Future, with Sujeet Naik Sujeet Naik, Analyst Sector Lead: John Mercer, Head of Global Research and Managing Director of Retail Research September 13, 2026 Reasons to ReadEach Analyst Corner features highlights and insights from the respective week’s “Report of the Week”—our featured must-read research report. This week, our featured report was Market Navigator: US Drugstore and Pharmacy Retailing—Solutions for Drugstores To Win Again. Discover how the US drugstore sector can build a stronger future by turning trusted pharmacist relationships into new healthcare services, improving pharmacy productivity and capturing emerging wellness opportunities. Read this report to uncover answers to these and other questions: How can US drugstores create a new playbook for growth by expanding clinical services, improving customer care and strengthening pharmacist-patient relationships? What market forces are shaping the US drugstore sector, including prescription drug price deflation, Medicare drug price negotiations under the Inflation Reduction Act and changing front-of-store demand? How can retailers capitalize on GLP-1 drug adoption by building recurring revenue through medication support, wellness services and complementary health offerings? How are major pharmacy chains responding to industry pressures, including store footprint reductions and evolving consumer expectations? Companies mentioned in this report include: CVS; Walgreens. Other relevant research: All Analyst Corners This document was generated for
